These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25264749)

  • 21. [Saxagliptin (Onglyza): new inhibitor of the dipeptidylpeptidase-4 for the oral treatment of type 2 diabetes].
    Scheen AJ
    Rev Med Liege; 2010 Sep; 65(9):527-32. PubMed ID: 21086586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cardiovascular effects of salidroside in the Goto-Kakizaki diabetic rat model.
    Alameddine A; Fajloun Z; Bourreau J; Gauquelin-Koch G; Yuan M; Gauguier D; Derbre S; Ayer A; Custaud MA; Navasiolava N
    J Physiol Pharmacol; 2015 Apr; 66(2):249-57. PubMed ID: 25903955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of voluntary running exercise on skeletal muscle properties in nonobese rats with type 2 diabetes.
    Nakamoto I; Ishihara A
    Physiol Res; 2020 Feb; 69(1):73-84. PubMed ID: 31852198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.
    Kosaraju J; Gali CC; Khatwal RB; Dubala A; Chinni S; Holsinger RM; Madhunapantula VS; Muthureddy Nataraj SK; Basavan D
    Neuropharmacology; 2013 Sep; 72():291-300. PubMed ID: 23603201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
    Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
    Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-intensity running exercise enhances the capillary volume and pro-angiogenic factors in the soleus muscle of type 2 diabetic rats.
    Kondo H; Fujino H; Murakami S; Tanaka M; Kanazashi M; Nagatomo F; Ishihara A; Roy RR
    Muscle Nerve; 2015 Mar; 51(3):391-9. PubMed ID: 24917153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise training attenuates oxidative stress and decreases p53 protein content in skeletal muscle of type 2 diabetic Goto-Kakizaki rats.
    Qi Z; He J; Zhang Y; Shao Y; Ding S
    Free Radic Biol Med; 2011 Apr; 50(7):794-800. PubMed ID: 21185935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway.
    He L; Zhang T; Sun W; Qin Y; Wang Z; Dong W; Zhang H
    Med Oncol; 2020 Oct; 37(11):97. PubMed ID: 33001278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise training boosts eNOS-dependent mitochondrial biogenesis in mouse heart: role in adaptation of glucose metabolism.
    Vettor R; Valerio A; Ragni M; Trevellin E; Granzotto M; Olivieri M; Tedesco L; Ruocco C; Fossati A; Fabris R; Serra R; Carruba MO; Nisoli E
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E519-28. PubMed ID: 24381004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of exercise on the nephron of Goto-Kakizaki rats: morphological, and advanced glycation end-products and inducible nitric oxide synthase immunohistochemical analyses.
    Tsutsumi E; Murata Y; Sakamoto M; Horikawa E
    J Diabetes Complications; 2015; 29(4):472-8. PubMed ID: 25817171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats.
    Mason RP; Jacob RF; Kubant R; Walter MF; Bellamine A; Jacoby A; Mizuno Y; Malinski T
    J Atheroscler Thromb; 2011; 18(9):774-83. PubMed ID: 21670556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saxagliptin: a review of its use as combination therapy in the management of type 2 diabetes mellitus in the EU.
    Yang LP
    Drugs; 2012 Jan; 72(2):229-48. PubMed ID: 22221000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.
    Schwartz SL
    Ann Med; 2012 Mar; 44(2):157-69. PubMed ID: 22132773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes.
    Ott C; Raff U; Schmidt S; Kistner I; Friedrich S; Bramlage P; Harazny JM; Schmieder RE
    Cardiovasc Diabetol; 2014 Jan; 13():19. PubMed ID: 24423149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saxagliptin Prevents Increased Coronary Vascular Stiffness in Aortic-Banded Mini Swine.
    Fleenor BS; Ouyang A; Olver TD; Hiemstra JA; Cobb MS; Minervini G; Emter CA
    Hypertension; 2018 Aug; 72(2):466-475. PubMed ID: 29891647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.
    Pollock C; Stefánsson B; Reyner D; Rossing P; Sjöström CD; Wheeler DC; Langkilde AM; Heerspink HJL
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):429-441. PubMed ID: 30992195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saxagliptin in type 2 diabetes.
    Billiones R
    Drugs Today (Barc); 2010 Feb; 46(2):101-8. PubMed ID: 20393638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
    Freeman JS
    Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S12-9. PubMed ID: 19952298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.
    Wang A; Dorso C; Kopcho L; Locke G; Langish R; Harstad E; Shipkova P; Marcinkeviciene J; Hamann L; Kirby MS
    BMC Pharmacol; 2012 Apr; 12():2. PubMed ID: 22475049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear SIRT1 activity, but not protein content, regulates mitochondrial biogenesis in rat and human skeletal muscle.
    Gurd BJ; Yoshida Y; McFarlan JT; Holloway GP; Moyes CD; Heigenhauser GJ; Spriet L; Bonen A
    Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R67-75. PubMed ID: 21543634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.